Recombinant DNA Technology Market Size, Share & Trends Analysis Report By Product (Medical, Non-medical), By Component (Expression System), By Application, By End Use, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
Rear Axle Market Growth & Trends
The global rear axle market size is expected to reach USD 73.1 billion by 2030, registering a CAGR of 4.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing concern over safety and security is anticipated to drive demand over the forecast period.
The increasing urbanization in the developed countries has led the consumers to seek alternatives to car ownership. Integrated mobility business and car-sharing has become the ongoing trend in the developed nations. The original equipment manufacturers are expected to diversify the product portfolio for offering services which include car-sharing to have a wider presence in all the diversified segments.
The increasing demand for value for money (VFM), which includes high mileage and fuel efficient products, is anticipated to catapult the vehicle industry. Developed markets, such as Europe and the U.S., represent the dominant share in the industry. Intense competition in the developed markets has led to a shift in the focus toward the emerging markets. Furthermore, the changing lifestyle, rise in disposable income, and stabilizing economic conditions have also led the emerging countries, such as India and China, to exhibit market growth.
The development of new technology, which includes connected cars, is a fully-digitized vehicle with advanced infotainment systems. Moreover, apps, Wi-Fi, and vehicle-to-vehicle communications have enhanced the basic safety such as position and speed, real-time location, and routing based on traffic conditions. Also, the development of smart cars, which provide a relinquishing control of vehicles with functions such as self-parking, self-braking, automatic accident avoidance features, automatic cruise control based on road conditions. The economic slowdown and falling stock prices have affected the sales of the automotive industry. China Association of Automobile Manufacturing (CAAM) confirmed a weaker growth of the sector as compared to that in 2014.
Rear Axle Market Report Highlights
Rear Axle Market Growth & Trends
The global rear axle market size is expected to reach USD 73.1 billion by 2030, registering a CAGR of 4.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing concern over safety and security is anticipated to drive demand over the forecast period.
The increasing urbanization in the developed countries has led the consumers to seek alternatives to car ownership. Integrated mobility business and car-sharing has become the ongoing trend in the developed nations. The original equipment manufacturers are expected to diversify the product portfolio for offering services which include car-sharing to have a wider presence in all the diversified segments.
The increasing demand for value for money (VFM), which includes high mileage and fuel efficient products, is anticipated to catapult the vehicle industry. Developed markets, such as Europe and the U.S., represent the dominant share in the industry. Intense competition in the developed markets has led to a shift in the focus toward the emerging markets. Furthermore, the changing lifestyle, rise in disposable income, and stabilizing economic conditions have also led the emerging countries, such as India and China, to exhibit market growth.
The development of new technology, which includes connected cars, is a fully-digitized vehicle with advanced infotainment systems. Moreover, apps, Wi-Fi, and vehicle-to-vehicle communications have enhanced the basic safety such as position and speed, real-time location, and routing based on traffic conditions. Also, the development of smart cars, which provide a relinquishing control of vehicles with functions such as self-parking, self-braking, automatic accident avoidance features, automatic cruise control based on road conditions. The economic slowdown and falling stock prices have affected the sales of the automotive industry. China Association of Automobile Manufacturing (CAAM) confirmed a weaker growth of the sector as compared to that in 2014.
Rear Axle Market Report Highlights
- The drive axle product segment dominated the global rear axle market with a revenue share of 54.8% in 2023. Drive axles are critical components in distributing power from the engine to the wheels, ensuring optimal performance in both commercial and passenger vehicles.
- The economy vehicles segment dominated the global rear axle market with a revenue share of 35.6% in 2023. Economy vehicles prioritize affordability, budget, and ROI, making them attractive to a wide range of consumers.
- Europe rear axle market dominated the global rear axle market with a revenue share of 34.9% in 2023. The region’s dominance is aided by its advanced automotive industry.
- Asia Pacific rear axle market is expected to register the fastest CAGR of 5.2% in the global rear axle market over the forecast period. Industry growth in the region is influenced by factors such as the growing automotive industry, increased demand for commercial vehicles, potential adoption of electric vehicles, technological advancements, and government support for sustainability.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. RECOMBINANT DNA TECHNOLOGY MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Billion)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Recombinant DNA Technology Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
CHAPTER 4. RECOMBINANT DNA TECHNOLOGY MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Recombinant DNA Technology Market: Product Movement Analysis, 2023 & 2030 (USD Billion)
4.3. Medical
4.3.1. Medical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.3.2. Therapeutic Agent
4.3.2.1. Therapeutic Agent Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.3.3. Human Protein
4.3.3.1. Human Protein Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.3.4. Vaccine
4.3.4.1. Vaccine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.4. Non-medical
4.4.1. Non-medical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.4.2. Biotech Crops
4.4.2.1. Biotech Crops Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.4.3. Specialty Chemicals
4.4.3.1. Specialty Chemicals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.4.4. Other Non-medical Products
4.4.4.1. Other Non-medical Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
CHAPTER 5. RECOMBINANT DNA TECHNOLOGY MARKET: COMPONENT ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Recombinant DNA Technology Market: Component Movement Analysis, 2023 & 2030 (USD Billion)
5.3. Expression System
5.3.1. Expression System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.3.2. Mammalian
5.3.2.1. Mammalian Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.3.3. Bacteria
5.3.3.1. Bacteria Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.3.4. Yeast
5.3.4.1. Yeast Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.3.5. Baculovirus / Insect
5.3.5.1. Baculovirus / Insect Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.3.6. Other Expression Systems
5.3.6.1. Other Expression Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.4. Cloning Vector
5.4.1. Cloning Vector Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
CHAPTER 6. RECOMBINANT DNA TECHNOLOGY MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Recombinant DNA Technology Market: Application Movement Analysis, 2023 & 2030 (USD Billion)
6.3. Food & Agriculture
6.3.1. Food & Agriculture Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.4. Health & Disease
6.4.1. Health & Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.4.2. Human
6.4.2.1. Human Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.4.3. Animal
6.4.3.1. Animal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.5. Other Applications
6.5.1. Other Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
CHAPTER 7. RECOMBINANT DNA TECHNOLOGY MARKET: END USE ESTIMATES & TREND ANALYSIS
7.1. Segment Dashboard
7.2. Recombinant DNA Technology Market: End Use Movement Analysis, 2023 & 2030 (USD Billion)
7.3. Biotechnology and Pharmaceutical Companies
7.3.1. Biotechnology and Pharmaceutical Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.4. Academic & Government Research Institutes
7.4.1. Academic & Government Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.5. Other End Uses
7.5.1. Other End Uses Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
CHAPTER 8. RECOMBINANT DNA TECHNOLOGY MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
8.1. Recombinant DNA Technology Market Share, By Region, 2023 & 2030 (USD Billion)
8.2. North America
8.2.1. North America Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.2.2. U.S.
8.2.2.1. U.S. Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.2.3. Canada
8.2.3.1. Canada Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.2.4. Mexico
8.2.4.1. Mexico Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3. Europe
8.3.1. Europe Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3.2. UK
8.3.2.1. UK Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3.3. Germany
8.3.3.1. Germany Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3.4. France
8.3.4.1. France Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3.5. Italy
8.3.5.1. Italy Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3.6. Spain
8.3.6.1. Spain Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3.7. Denmark
8.3.7.1. Denmark Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3.8. Sweden
8.3.8.1. Sweden Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3.9. Norway
8.3.9.1. Norway Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.4. Asia Pacific
8.4.1. Asia Pacific Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.4.2. Japan
8.4.2.1. Japan Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.4.3. China
8.4.3.1. China Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.4.4. India
8.4.4.1. India Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.4.5. South Korea
8.4.5.1. South Korea Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.4.6. Australia
8.4.6.1. Australia Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.4.7. Thailand
8.4.7.1. Thailand Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.5. Latin America
8.5.1. Latin America Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.5.2. Brazil
8.5.2.1. Brazil Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.5.3. Argentina
8.5.3.1. Argentina Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.6. Middle East and Africa
8.6.1. Middle East and Africa Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.6.2. South Africa
8.6.2.1. South Africa Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.6.3. Saudi Arabia
8.6.3.1. Saudi Arabia Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.6.4. UAE
8.6.4.1. UAE Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.6.5. Kuwait
8.6.5.1. Kuwait Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
CHAPTER 9. COMPETITIVE LANDSCAPE
9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
9.4.1. Pfizer Inc.
9.4.1.1. Participant’s Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Recent Developments/Strategic Initiatives
9.4.2. Sanofi
9.4.2.1. Participant’s Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Recent Developments/Strategic Initiatives
9.4.3. New England Biolabs
9.4.3.1. Participant’s Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Recent Developments/Strategic Initiatives
9.4.4. GlaxoSmithKline plc
9.4.4.1. Participant’s Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Recent Developments/Strategic Initiatives
9.4.5. GenScript
9.4.5.1. Participant’s Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Recent Developments/Strategic Initiatives
9.4.6. Thermo Fisher Scientific Inc.
9.4.6.1. Participant’s Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Recent Developments/Strategic Initiatives
9.4.7. Biogen Inc.
9.4.7.1. Participant’s Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Recent Developments/Strategic Initiatives
9.4.8. Merck & Co., Inc.
9.4.8.1. Participant’s Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Recent Developments/Strategic Initiatives
9.4.9. Amgen Inc.
9.4.9.1. Participant’s Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Recent Developments/Strategic Initiatives
9.4.10. Monsanto Company
9.4.10.1. Participant’s Overview
9.4.10.2. Financial Performance
9.4.10.3. Product Benchmarking
9.4.10.4. Recent Developments/Strategic Initiatives
9.4.11. F. Hoffmann-La Roche Ltd
9.4.11.1. Participant’s Overview
9.4.11.2. Financial Performance
9.4.11.3. Product Benchmarking
9.4.11.4. Recent Developments/Strategic Initiatives
9.4.12. Novartis AG
9.4.12.1. Participant’s Overview
9.4.12.2. Financial Performance
9.4.12.3. Product Benchmarking
9.4.12.4. Recent Developments/Strategic Initiatives
9.4.13. Eli Lilly and Company
9.4.13.1. Participant’s Overview
9.4.13.2. Financial Performance
9.4.13.3. Product Benchmarking
9.4.13.4. Recent Developments/Strategic Initiatives
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. RECOMBINANT DNA TECHNOLOGY MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Billion)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Recombinant DNA Technology Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
CHAPTER 4. RECOMBINANT DNA TECHNOLOGY MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Recombinant DNA Technology Market: Product Movement Analysis, 2023 & 2030 (USD Billion)
4.3. Medical
4.3.1. Medical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.3.2. Therapeutic Agent
4.3.2.1. Therapeutic Agent Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.3.3. Human Protein
4.3.3.1. Human Protein Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.3.4. Vaccine
4.3.4.1. Vaccine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.4. Non-medical
4.4.1. Non-medical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.4.2. Biotech Crops
4.4.2.1. Biotech Crops Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.4.3. Specialty Chemicals
4.4.3.1. Specialty Chemicals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.4.4. Other Non-medical Products
4.4.4.1. Other Non-medical Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
CHAPTER 5. RECOMBINANT DNA TECHNOLOGY MARKET: COMPONENT ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Recombinant DNA Technology Market: Component Movement Analysis, 2023 & 2030 (USD Billion)
5.3. Expression System
5.3.1. Expression System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.3.2. Mammalian
5.3.2.1. Mammalian Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.3.3. Bacteria
5.3.3.1. Bacteria Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.3.4. Yeast
5.3.4.1. Yeast Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.3.5. Baculovirus / Insect
5.3.5.1. Baculovirus / Insect Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.3.6. Other Expression Systems
5.3.6.1. Other Expression Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.4. Cloning Vector
5.4.1. Cloning Vector Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
CHAPTER 6. RECOMBINANT DNA TECHNOLOGY MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Recombinant DNA Technology Market: Application Movement Analysis, 2023 & 2030 (USD Billion)
6.3. Food & Agriculture
6.3.1. Food & Agriculture Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.4. Health & Disease
6.4.1. Health & Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.4.2. Human
6.4.2.1. Human Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.4.3. Animal
6.4.3.1. Animal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.5. Other Applications
6.5.1. Other Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
CHAPTER 7. RECOMBINANT DNA TECHNOLOGY MARKET: END USE ESTIMATES & TREND ANALYSIS
7.1. Segment Dashboard
7.2. Recombinant DNA Technology Market: End Use Movement Analysis, 2023 & 2030 (USD Billion)
7.3. Biotechnology and Pharmaceutical Companies
7.3.1. Biotechnology and Pharmaceutical Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.4. Academic & Government Research Institutes
7.4.1. Academic & Government Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
7.5. Other End Uses
7.5.1. Other End Uses Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
CHAPTER 8. RECOMBINANT DNA TECHNOLOGY MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
8.1. Recombinant DNA Technology Market Share, By Region, 2023 & 2030 (USD Billion)
8.2. North America
8.2.1. North America Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.2.2. U.S.
8.2.2.1. U.S. Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.2.3. Canada
8.2.3.1. Canada Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.2.4. Mexico
8.2.4.1. Mexico Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3. Europe
8.3.1. Europe Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3.2. UK
8.3.2.1. UK Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3.3. Germany
8.3.3.1. Germany Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3.4. France
8.3.4.1. France Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3.5. Italy
8.3.5.1. Italy Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3.6. Spain
8.3.6.1. Spain Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3.7. Denmark
8.3.7.1. Denmark Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3.8. Sweden
8.3.8.1. Sweden Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.3.9. Norway
8.3.9.1. Norway Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.4. Asia Pacific
8.4.1. Asia Pacific Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.4.2. Japan
8.4.2.1. Japan Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.4.3. China
8.4.3.1. China Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.4.4. India
8.4.4.1. India Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.4.5. South Korea
8.4.5.1. South Korea Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.4.6. Australia
8.4.6.1. Australia Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.4.7. Thailand
8.4.7.1. Thailand Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.5. Latin America
8.5.1. Latin America Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.5.2. Brazil
8.5.2.1. Brazil Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.5.3. Argentina
8.5.3.1. Argentina Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.6. Middle East and Africa
8.6.1. Middle East and Africa Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.6.2. South Africa
8.6.2.1. South Africa Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.6.3. Saudi Arabia
8.6.3.1. Saudi Arabia Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.6.4. UAE
8.6.4.1. UAE Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
8.6.5. Kuwait
8.6.5.1. Kuwait Recombinant DNA Technology Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
CHAPTER 9. COMPETITIVE LANDSCAPE
9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
9.4.1. Pfizer Inc.
9.4.1.1. Participant’s Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Recent Developments/Strategic Initiatives
9.4.2. Sanofi
9.4.2.1. Participant’s Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Recent Developments/Strategic Initiatives
9.4.3. New England Biolabs
9.4.3.1. Participant’s Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Recent Developments/Strategic Initiatives
9.4.4. GlaxoSmithKline plc
9.4.4.1. Participant’s Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Recent Developments/Strategic Initiatives
9.4.5. GenScript
9.4.5.1. Participant’s Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Recent Developments/Strategic Initiatives
9.4.6. Thermo Fisher Scientific Inc.
9.4.6.1. Participant’s Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Recent Developments/Strategic Initiatives
9.4.7. Biogen Inc.
9.4.7.1. Participant’s Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Recent Developments/Strategic Initiatives
9.4.8. Merck & Co., Inc.
9.4.8.1. Participant’s Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Recent Developments/Strategic Initiatives
9.4.9. Amgen Inc.
9.4.9.1. Participant’s Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Recent Developments/Strategic Initiatives
9.4.10. Monsanto Company
9.4.10.1. Participant’s Overview
9.4.10.2. Financial Performance
9.4.10.3. Product Benchmarking
9.4.10.4. Recent Developments/Strategic Initiatives
9.4.11. F. Hoffmann-La Roche Ltd
9.4.11.1. Participant’s Overview
9.4.11.2. Financial Performance
9.4.11.3. Product Benchmarking
9.4.11.4. Recent Developments/Strategic Initiatives
9.4.12. Novartis AG
9.4.12.1. Participant’s Overview
9.4.12.2. Financial Performance
9.4.12.3. Product Benchmarking
9.4.12.4. Recent Developments/Strategic Initiatives
9.4.13. Eli Lilly and Company
9.4.13.1. Participant’s Overview
9.4.13.2. Financial Performance
9.4.13.3. Product Benchmarking
9.4.13.4. Recent Developments/Strategic Initiatives
